Omnicell (OMCL) Tops Q2 EPS by 6c; Issues Solid Outlook

Omnicell (NASDAQ: OMCL) reported Q2 EPS of $0.38, $0.06 better than the analyst estimate of $0.32. Revenue for the quarter came in at $175.6 million versus the consensus estimate of $170.89 million.

GUIDANCE:

Omnicell sees Q3 2016 EPS of $0.38-$0.48, versus the consensus of $0.40. Omnicell sees Q3 2016 revenue of $176-183 million, versus the consensus of $178.4 million.

Omnicell sees FY2016 EPS of $1.50-$1.60, versus the consensus of $1.56. Omnicell sees FY2016 revenue of $695-715 million, versus the consensus of $706.5 million.

For earnings history and earnings-related data on Omnicell (OMCL) click here.

You May Also Be Interested In

• United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
• Bernstein SocGen Group Reiterates Outperform Rating on Robinhood Markets (HOOD)
• Labcorp acquires MLM Medical Labs to expand lab network